Document Detail

Commercialization of animal biotechnology.
MedLine Citation:
PMID:  12499024     Owner:  NLM     Status:  MEDLINE    
Commercialization of animal biotechnology is a wide-ranging topic for discussion. In this paper, we will attempt to review embryo transfer (ET) and related technologies that relate to food-producing mammals. A brief review of the history of advances in biotechnology will provide a glimpse to present and future applications. Commercialization of animal biotechnology is presently taking two pathways. The first application involves the use of animals for biomedical purposes. Very few companies have developed all of the core competencies and intellectual properties to complete the bridge from lab bench to product. The second pathway of application is for the production of animals used for food. Artificial insemination (AI), embryo transfer, in vitro fertilization (IVF), cloning, transgenics, and genomics all are components of the toolbox for present and future applications. Individually, these are powerful tools capable of providing significant improvements in productivity. Combinations of these technologies coupled with information systems and data analysis, will provide even more significant change in the next decade. Any strategies for the commercial application of animal biotechnology must include a careful review of regulatory and social concerns. Careful review of industry infrastructure is also important. Our colleagues in plant biotechnology have helped highlight some of these pitfalls and provide us with a retrospective review. In summary, today we have core competencies that provide a wealth of opportunities for the members of this society, commercial companies, producers, and the general population. Successful commercialization will benefit all of the above stakeholders.
D C Faber; J A Molina; C L Ohlrichs; D F Vander Zwaag; L B Ferré
Related Documents :
455084 - Effects of intranasal irrigation with mitotic inhibitors on olfactory behavior and bioc...
12793784 - Protein nutrition for ruminants in european countries, in the light of animal feeding r...
23088604 - Reply to: environ. sci. technol., 2012, 46(7), pp 3795-3802. "feather meal: a previousl...
954724 - Growth rate in thoroughbred yearlings and two year olds.
11908604 - Extension of the color suite available for chemical enhancement of fingerprints in blood.
24915384 - Flavonoids and immune function in human: a systematic review.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Theriogenology     Volume:  59     ISSN:  0093-691X     ISO Abbreviation:  Theriogenology     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2002-12-24     Completed Date:  2003-03-13     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0421510     Medline TA:  Theriogenology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  125-38     Citation Subset:  IM    
Copyright Information:
Copyright 2002 Elsevier Science Inc.
Trans Ova Genetics, 2938 380th Street, Sioux Center, IA 51250-7075, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biomedical Technology
Cloning, Organism
Embryo Transfer / veterinary
Fertilization in Vitro / veterinary
Food Technology
Reproductive Techniques, Assisted / veterinary*
Sex Preselection

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Transgenic swine for biomedicine and agriculture.
Next Document:  New commercial opportunities for advanced reproductive technologies in horses, wildlife, and compani...